X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 05/Sep 13:42

Cannabis Stock CRON Trades Near 52-Week High: How to Play

Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.

Articles similaires

Sorry! Image not available at this time

AMAT Trades 54% Above Its 52-Week Low: Time to Hold or Fold the Stock?

zacks.com - 22/Sep 15:42

Applied Materials rides DRAM strength and R&D push, but China headwinds, weak memory demand and rivals weigh on its outlook.

Sorry! Image not available at this time

ADBE's AI Push Gains Traction: Buy or Hold the Stock Post Q3 Earnings?

zacks.com - 15/Sep 16:17

Adobe's AI-fueled growth lifts Q3 revenues and ARR, but stretched valuation and stiff competition weigh on the stock's outlook.

Sorry! Image not available at this time

Figma Drops 29% in a Month: Buy, Sell or Hold the FIG Stock?

zacks.com - 16/Sep 16:23

FIG slides as slowing growth, stiff competition, and margin pressure weigh against its expanding AI-powered product lineup.

Sorry! Image not available at this time

UPS Terminates Estafeta Deal: How Should You Approach the Stock Now?

zacks.com - 22/Sep 15:55

UPS cancels its Estafeta acquisition as weak demand, high inflation and falling volumes weigh on the delivery giant's outlook.

Sorry! Image not available at this time

lululemon Trades Near 52-Week Low: Buy Opportunity or Time to Sell?

zacks.com - 22/Sep 16:24

LULU shares hover near a 52-week low as weak U.S. trends, tariff pressures and slashed guidance weigh on investor sentiment.

Sorry! Image not available at this time

ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?

zacks.com - 15/Sep 13:01

Intuitive Surgical shares are down 13% in three months as margin pressures weigh on the stock, but strong procedure growth keeps its long-term story...

Sorry! Image not available at this time

Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now?

zacks.com - 16/Sep 12:20

Myriad Genetics expands oncology testing and launches new diagnostics, but inflation and rising competition weigh on its outlook.

Sorry! Image not available at this time

B2Gold Stock Hits 52-Week High: What's Driving Its Performance?

zacks.com - 23/Sep 16:43

BTG shares hit a 52-week high as record gold prices, strong mine output and a firm 2025 production outlook boost momentum.

Sorry! Image not available at this time

B2Gold Stock Hits 52-Week High: What's Driving Its Performance?

zacks.com - 23/Sep 16:43

BTG shares hit a 52-week high as record gold prices, strong mine output and a firm 2025 production outlook boost momentum.

Sorry! Image not available at this time

Reasons to Add Labcorp Stock to Your Portfolio Right Now

zacks.com - 23/Sep 12:22

LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.

Les derniers communiqués